Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Frier Levitt Launches Maximum Allowable Cost (MAC) Reimbursement Rights Practice Group Helping Pharmacies Fight Unfair Pharmacy Benefit Manager (PBM) Practice


PINE BROOK, N.J., March 15, 2018 /PRNewswire/ -- As part of its ongoing mission to protect Independent Pharmacies nationally, boutique healthcare law firm Frier Levitt announced today the establishment of a firm Practice Group focused exclusively on Maximum Allowable Cost (MAC) reimbursement.  

Frier Levitt's MAC Pricing Practice Group, led by Lucas W. Morgan, Esq., assists pharmacies in fighting unfair MAC reimbursements by Pharmacy Benefit Managers (PBMs), examines the legality of PBMs' MAC pricing, MAC reimbursement, and ensures that pharmacies take advantage of state laws restraining unfair PBM practices.

Frier Levitt has observed troubling trends pertaining to PBMs' MAC practices, including how MAC pricing is determined, MAC reimbursement to pharmacies, and the amount charged to plan sponsors. Because there is no generally accepted reference price for multisource generic drugs, pharmacies are usually reimbursed by PBMs for these drugs based on a MAC price list created by the PBM. MAC prices are usually set by the PBM with pharmacies having no access to the methodology utilized by the PBM.

Pharmacies that dispense a substantial amount of multisource generic drugs and have questions or concerns regarding PBM MAC practices should contact Lucas W. Morgan, Esq. at [email protected] or call 973.618.1660. 

About Frier Levitt, LLC

Frier Levitt is a national boutique healthcare law firm, providing comprehensive regulatory, transactional and litigation counsel to the Life Sciences and Healthcare industries, drawing on experience representing stakeholders from all ends of the healthcare spectrum. Frier Levitt represents pharmacies of all kinds, including specialty pharmacies, retail pharmacies, compounding pharmacies, chain pharmacies, mail order pharmacies, home infusion and long-term care pharmacies, and publicly-traded specialty pharmacies. Through our experience in representing thousands of pharmacies, we have developed strong relationships with key decision-makers at each pharmacy benefits manager, as well as a keen understanding of the dynamic trends and legal issues impacting pharmacies. For more information, visit www.frierlevitt.com.

SOURCE Frier Levitt, LLC


These press releases may also interest you

at 12:57
Hinkal Closes Strategic Funding Round to Advance Discreet Trading and Position Liquidation
Hinkal, a multi-chain privacy layer for confidential decentralized finance (DeFi) transactions, today announced a $1.4 million strategic funding round led by SALT Fund, with participation from Draper Associates, SNZ and Peer VC. Additionally, Tal...

at 12:45
Sogolytics Study Examines Patient Experience Gaps in Telehealth Adoption
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:39
Interfuse Adds New Features to its Knowledge Base
In an effort to provide the best service possible, enterprise developer Interfuse, has added several important improvements to its Knowledge Base application. Within this update, new pages accessible in the Knowledge Base include Recently Added,...

at 12:16
Amae Health, Innovative Treatment Provider for Severe Mental Illness, Announces Closing of Oversubscribed $15 Million Series A Funding Round
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:05
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadranttm for Supply Chain Planning Solutions
Kinaxis® Inc. , a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadranttm for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis...

at 12:05
Radiance Biopharma to Present at LSX World Congress 2024
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...

More news about Science and technology...


News published on and distributed by: